Literature DB >> 27304551

Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment.

Veronica Tisato1, Erika Rimondi, Gloria Brombo, Stefano Volpato, Amedeo Zurlo, Giorgio Zauli, Paola Secchiero, Giovanni Zuliani.   

Abstract

BACKGROUND: The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been involved in both physiological and pathological conditions, including vascular pathologies and pathologies of the central nervous system. Nonetheless, the knowledge about the role of systemic TRAIL in patients affected by different types of dementia and mild cognitive impairment (MCI) is still limited.
OBJECTIVE: We assessed serum TRAIL levels in a large cohort of older individuals (n = 644) including patients with late-onset Alzheimer's disease (LOAD), vascular dementia (VAD), 'mixed' dementia (MIX), MCI, and healthy controls.
METHODS: Circulating TRAIL was measured by ELISA.
RESULTS: At univariate analysis, TRAIL levels were higher in VAD, MIX, and MCI patients compared with LOAD patients and controls. Using the multiple linear regression model, we found that TRAIL levels were associated with VAD and MCI, but not MIX, independent of potential confounding factors.
CONCLUSION: The finding of high levels of circulating TRAIL in VAD and MCI seems to suggest that both of these conditions are characterized by a significant vascular damage with respect to LOAD.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27304551     DOI: 10.1159/000446275

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  8 in total

1.  Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.

Authors:  Veronica Tisato; Giovanni Zuliani; Marco Vigliano; Giovanna Longo; Eugenia Franchini; Paola Secchiero; Giorgio Zauli; Elvezia Maria Paraboschi; Ajay Vikram Singh; Maria Luisa Serino; Beatrice Ortolani; Amedeo Zurlo; Cristina Bosi; Antonio Greco; Davide Seripa; Rosanna Asselta; Donato Gemmati
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

Review 2.  TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?

Authors:  Stella Bernardi; Rebecca Voltan; Erika Rimondi; Elisabetta Melloni; Daniela Milani; Carlo Cervellati; Donato Gemmati; Claudio Celeghini; Paola Secchiero; Giorgio Zauli; Veronica Tisato
Journal:  Clin Sci (Lond)       Date:  2019-05-16       Impact factor: 6.124

Review 3.  Insight into the divergent role of TRAIL in non-neoplastic neurological diseases.

Authors:  Shiqi Gao; Yuanjian Fang; Sheng Tu; Huaijun Chen; Anwen Shao
Journal:  J Cell Mol Med       Date:  2020-08-22       Impact factor: 5.310

Review 4.  Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment.

Authors:  Vismitha Rajeev; David Y Fann; Quynh Nhu Dinh; Hyun Ah Kim; T Michael De Silva; Mitchell K P Lai; Christopher Li-Hsian Chen; Grant R Drummond; Christopher G Sobey; Thiruma V Arumugam
Journal:  Theranostics       Date:  2022-01-16       Impact factor: 11.556

Review 5.  Research progress on cognitive impairment and the expression of serum inflammatory markers in patients with white matter hyperintensities: a narrative review.

Authors:  Shanshan Qiao; Haitao Li; Fang Guo; Guilan Cai; Yongbo Zhang
Journal:  Ann Transl Med       Date:  2022-04

6.  TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress.

Authors:  Veronica Tisato; Stefania Gallo; Elisabetta Melloni; Claudio Celeghini; Angelina Passaro; Giorgio Zauli; Paola Secchiero; Carlo Bergamini; Alessandro Trentini; Gloria Bonaccorsi; Giuseppe Valacchi; Giovanni Zuliani; Carlo Cervellati
Journal:  Mediators Inflamm       Date:  2018-07-26       Impact factor: 4.711

7.  Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women.

Authors:  Veronica Tisato; Paola Secchiero; Gloria Bonaccorsi; Carlo Bergamini; Pantaleo Greco; Giorgio Zauli; Carlo Cervellati
Journal:  Mediators Inflamm       Date:  2017-09-05       Impact factor: 4.711

Review 8.  "Bridging the Gap" Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era.

Authors:  Donato Gemmati; Katia Varani; Barbara Bramanti; Roberta Piva; Gloria Bonaccorsi; Alessandro Trentini; Maria Cristina Manfrinato; Veronica Tisato; Alessandra Carè; Tiziana Bellini
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.